
Research and updates from all @FrontiersIn journals in the field of oncology. #openaccess
Lausanne, Switzerland
Joined October 2011
- Tweets28.3K
- Following617
- Followers6.5K
- Likes6.5K
Pinned Tweet
Your research is the real superpower. The latest impact metrics for Frontiers in Oncology are here: a Journal Impact Factor of 3.4 and a CiteScore of 6.6.
Congratulations to the community helping research drive real-world change.
Explore the journal ⬇️
New Research: The ZMAGE-A3 affitoxin 172-cpp has great potential for targeting therapy of tumors www.frontiersin.org/articles/10.3389/fonc.2026.1862676 #FrontiersIn #Oncology
New Research: Comparative effects of exercise and nutritional interventions on muscle mass and body composition in adults with cancer: a systematic review and network meta-analysis of… www.frontiersin.org/articles/10.3389/or.2026.1926991 #FrontiersIn #OncologyReviews
New Research: Anti-Homer3 antibody-positive autoimmune cerebellar ataxia associated with diffuse large B-cell lymphoma: a case report www.frontiersin.org/articles/10.3389/frhem.2026.1967079
New Research: Mortality trends and high-risk subgroups in hematologic malignancy-associated pulmonary embolism: a population-based analysis with complementary clinical data www.frontiersin.org/articles/10.3389/fonc.2026.1989633 #FrontiersIn #Oncology
New Research: Case Report: High-level RUNX1/21q22 amplification is associated with multiple cytogenetic abnormalities and TP53 gene mutation in a refractory AML patient with poor clinical outcome www.frontiersin.org/articles/10.3389/frhem.2026.1928502
New Research: Neurological syndrome with CSF anti-Hu positivity during serplulimab therapy in extensive-stage small-cell lung cancer: a case report www.frontiersin.org/articles/10.3389/fonc.2026.1974779 #FrontiersIn #Oncology
New Research: Immune surveillance and emerging immunogenetic modifiers in CALR-mutated myeloproliferative neoplasms www.frontiersin.org/articles/10.3389/frhem.2026.1969104
New Research: Primary resistance to afatinib in a patient with NSCLC harboring EGFR p.E709_T710delinsD and brain metastases: a case report and literature review www.frontiersin.org/articles/10.3389/fonc.2026.1981577 #FrontiersIn #Oncology
New Research: Outcomes of sequential microvascular tissue transfer for radiation induced sequelae post mandibular reconstruction www.frontiersin.org/articles/10.3389/fonc.2026.1897431 #FrontiersIn #Oncology
New Research: Prognostic significance of lymph node staging in esophageal squamous cell carcinoma after neoadjuvant chemoimmunotherapy www.frontiersin.org/articles/10.3389/fonc.2026.1931817 #FrontiersIn #Oncology
New Research: Cardio-respiratory-gated proton pencil beam scanning for cardiac ablation: workflow and end-to-end validation www.frontiersin.org/articles/10.3389/fonc.2026.1923998 #FrontiersIn #Oncology
⏳ 1 month until submissions close!
Submit to our Research Topic on "Vascular Dynamics and Immune Modulation in Tumor Progression"
👉 fro.ntiers.in/70389ext
Led by Yiming Zhou, Qingtang Lin, GUANGHUA Rong, Yunfeng Feng, Shin-chen Hou & Zuqiang Liu
#callforpapers #openaccess
New Research: Can the prognostic nutritional index predict survival in patients with gastric and esophagogastric junction adenocarcinoma? www.frontiersin.org/articles/10.3389/fonc.2026.1872975 #FrontiersIn #Oncology
New Research: Erianin suppresses prostate cancer progression and attenuates STAT3 signaling www.frontiersin.org/articles/10.3389/fonc.2026.1975408 #FrontiersIn #Oncology
New Research: Global and regional gastric cancer burden and age-related survival disparities: complementary analyses of GBD 2021 and SEER data www.frontiersin.org/articles/10.3389/fonc.2026.1880227 #FrontiersIn #Oncology
New Research: Narrative review of non-pharmacological interventions for chemotherapy-induced peripheral neuropathy: exercise, physical therapy, cryotherapy and acupuncture www.frontiersin.org/articles/10.3389/or.2026.1922088 #FrontiersIn #OncologyReviews
New Research: A modified ovarian-adnexal reporting and data system ultrasound for differentiating ovarian carcinoma: integration of the risk of malignancy algorithm into the American College of… www.frontiersin.org/articles/10.3389/fonc.2026.1962862 #FrontiersIn #Oncology
New Research: Chinese herbal medicine combined with conventional therapy for gastric precancerous lesions: a systematic review and meta-analysis www.frontiersin.org/articles/10.3389/or.2026.1947905 #FrontiersIn #OncologyReviews
New Research: A predefined sulphur-handling transcriptional programme is associated with colorectal cancer molecular subtypes www.frontiersin.org/articles/10.3389/fonc.2026.1976885 #FrontiersIn #Oncology
New Research: Pretransplant plasma soluble PD-1 and recurrence after liver transplantation in ICI-treated hepatocellular carcinoma: an exploratory biomarker study www.frontiersin.org/articles/10.3389/fonc.2026.1944586 #FrontiersIn #Oncology


